Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 31INDUSTRY 3UNKNOWN 2NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Stomach Neoplasms 1Rectal Neoplasms 1

Interventions

S 1 (combination) 16Paclitaxel 11Oxaliplatin 10Capecitabine 10Cisplatin 7Irinotecan 6titanium silicide 5sintilimab 4nimotuzumab 4nedaplatin 4TP protocol 3HMPL-013 3Fluorouracil 3Bevacizumab 3130-nm albumin-bound paclitaxel 3toripalimab 2raltitrexed 2Trastuzumab 2Tegafur 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2Radiotherapy, Adjuvant 2Radiosurgery 2Radiation 2Neoadjuvant Therapy 2Leucovorin 2Esophagectomy 2Docetaxel 2Chemotherapy, Adjuvant 2Albumin-Bound Paclitaxel 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
UNKNOWN × raltitrexed × Gastrointestinal × Clear all
NCT02992886 2021-09-09

Preoperative Chemoradiotherapy With Raltitrexed for Intermediate or Locally Advanced Rectal Cancer in the Fit Elderly

ChineseAMS

Phase 2 Completed
68 enrolled
Gastrointestinal

Rectal Neoplasms

NCT03083613 2021-02-01

Raltitrexed and Paclitaxel for Gastric or Gastroesophageal Junction Adenocarcinoma

ChineseAMS

Phase 2 Completed
41 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡